PharmaCorp Announces Grant of Stock Options
(TSX-V:PCRX), SASKATOON, Saskatchewan, Dec. 31, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation“) (TSXV: PCRX) has granted a total of 501,088 options to purchase common ‎shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.46 and ‎an expiry date of December 31, 2035, subject to approval […]